These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26288691)

  • 21. The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design.
    Oosterveer MH; Grefhorst A; Groen AK; Kuipers F
    Prog Lipid Res; 2010 Oct; 49(4):343-52. PubMed ID: 20363253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver X receptors interact with corepressors to regulate gene expression.
    Hu X; Li S; Wu J; Xia C; Lala DS
    Mol Endocrinol; 2003 Jun; 17(6):1019-26. PubMed ID: 12663743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C24-hydroxylated stigmastane derivatives as Liver X Receptor agonists.
    Castro Navas FF; Giorgi G; Maggioni D; Pacciarini M; Russo V; Marinozzi M
    Chem Phys Lipids; 2018 May; 212():44-50. PubMed ID: 29352964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of LXRs using the synthetic agonist GW3965 represses the production of pro-inflammatory cytokines by murine mast cells.
    Nunomura S; Okayama Y; Matsumoto K; Hashimoto N; Endo-Umeda K; Terui T; Makishima M; Ra C
    Allergol Int; 2015 Sep; 64 Suppl():S11-7. PubMed ID: 26344074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver X receptor: from metabolism to cancer.
    Venteclef N; Ferré P
    Biochem J; 2014 Apr; 459(2):e1-3. PubMed ID: 24678940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural modulators of liver X receptors.
    Huang C
    J Integr Med; 2014 Mar; 12(2):76-85. PubMed ID: 24666673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of 5α, 6α-epoxycholesterol as a novel modulator of liver X receptor activity.
    Berrodin TJ; Shen Q; Quinet EM; Yudt MR; Freedman LP; Nagpal S
    Mol Pharmacol; 2010 Dec; 78(6):1046-58. PubMed ID: 20837678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological role of liver X receptors.
    Baranowski M
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 7():31-55. PubMed ID: 19258656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting liver X receptors in inflammation.
    Steffensen KR; Jakobsson T; Gustafsson JÅ
    Expert Opin Ther Targets; 2013 Aug; 17(8):977-90. PubMed ID: 23738533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of liver X receptor suppresses osteopontin expression and ameliorates nephrolithiasis.
    Chen J; Zhang D; Ji MF; Liu T; Mei CL; Tang XJ
    J Cell Physiol; 2019 Aug; 234(8):14109-14122. PubMed ID: 30623435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective activation of liver X receptors by acanthoic acid-related diterpenes.
    Traves PG; Hortelano S; Zeini M; Chao TH; Lam T; Neuteboom ST; Theodorakis EA; Palladino MA; Castrillo A; Bosca L
    Mol Pharmacol; 2007 Jun; 71(6):1545-53. PubMed ID: 17329499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LXR Suppresses Inflammatory Gene Expression and Neutrophil Migration through cis-Repression and Cholesterol Efflux.
    Thomas DG; Doran AC; Fotakis P; Westerterp M; Antonson P; Jiang H; Jiang XC; Gustafsson JÅ; Tabas I; Tall AR
    Cell Rep; 2018 Dec; 25(13):3774-3785.e4. PubMed ID: 30590048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and activity evaluation of a series of cholanamides as modulators of the liver X receptors.
    Martínez MD; Ghini AA; Dansey MV; Veleiro AS; Pecci A; Alvarez LD; Burton G
    Bioorg Med Chem; 2018 Mar; 26(5):1092-1101. PubMed ID: 29428525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of lipopolysaccharide-induced gene expression by liver X receptor ligands in macrophages involves interference with early growth response factor 1.
    Guillem-Llobat P; Íñiguez MA
    Prostaglandins Leukot Essent Fatty Acids; 2015 May; 96():37-49. PubMed ID: 25736222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Destabilization of the torsioned conformation of a ligand side chain inverts the LXRβ activity.
    Álvarez LD; Dansey MV; Grinman DY; Navalesi D; Samaja GA; Del Fueyo MC; Bastiaensen N; Houtman R; Estrin DA; Veleiro AS; Pecci A; Burton G
    Biochim Biophys Acta; 2015 Dec; 1851(12):1577-86. PubMed ID: 26434697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands.
    Löwenberg M; Stahn C; Hommes DW; Buttgereit F
    Steroids; 2008 Oct; 73(9-10):1025-9. PubMed ID: 18221974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic opportunities for liver X receptor modulators.
    Collins JL
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):692-702. PubMed ID: 15503871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological mechanisms and related natural modulators of liver X receptor in nonalcoholic fatty liver disease.
    Ni M; Zhang B; Zhao J; Feng Q; Peng J; Hu Y; Zhao Y
    Biomed Pharmacother; 2019 May; 113():108778. PubMed ID: 30897538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver X receptor agonists inhibit tissue factor expression in macrophages.
    Terasaka N; Hiroshima A; Ariga A; Honzumi S; Koieyama T; Inaba T; Fujiwara T
    FEBS J; 2005 Mar; 272(6):1546-56. PubMed ID: 15752369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small heterodimer partner SHP mediates liver X receptor (LXR)-dependent suppression of inflammatory signaling by promoting LXR SUMOylation specifically in astrocytes.
    Lee JH; Kim H; Park SJ; Woo JH; Joe EH; Jou I
    Sci Signal; 2016 Aug; 9(439):ra78. PubMed ID: 27485016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.